{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:32:33Z","timestamp":1794335553438,"version":"4.9.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":1269,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pediatric pulmonary hypertension is an important cause of childhood morbidity and mortality, but there are limited data on the range of associated diseases, contributions of different pulmonary hypertension subtypes, therapeutic strategies, and clinical outcomes in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To report the 20-year experience of a large UK National Pediatric Pulmonary Hypertension Service focusing on epidemiology and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive patients presenting between 2001 and 2021 were included, and survival analysis was performed for incident patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Of 1,353 patients assessed, a pulmonary hypertension diagnosis was made in 1,101 (81.4%) patients (51% female, median age, 2.6 [interquartile range, 0.8\u20138.2] years). The most common form was pulmonary arterial hypertension in 48%, followed by 32.3% with pulmonary hypertension due to lung disease. Multiple contributory causes of pulmonary hypertension were common, with 16.9% displaying features of more than one diagnostic group. The annual incidence of childhood pulmonary hypertension was 3.5 (95% confidence interval [CI], 3.3\u20133.8) per 1 million children, and the prevalence was 18.1 (95% CI, 15.8\u201320.4) per 1 million. The incidence was highest for pulmonary hypertension due to lung disease in infancy (15.0 [95% CI, 12.7\u201317.2] per 1 million per year). Overall, 82.4% patients received pulmonary arterial hypertension therapy, and escalation to triple therapy during follow-up was required in 13.1%. In 970 (88.1%) incident patients, transplant-free survival was 86.7% (95% CI, 84.5\u201389%) at 1 and 68.6% (95% CI, 64.7\u201372.6%) at 10 years. Pulmonary hypertension due to left heart disease had the lowest survival (hazard ratio, 2.0; 95% CI, 1.36\u20132.94; P\u2009&amp;lt;\u20090.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clinical phenotypes of pediatric pulmonary hypertension are heterogeneous and overlapping, with clinical phenotypes that evolve throughout childhood. Despite widespread use of pulmonary arterial hypertension therapy, the prognosis remains poor.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202110-2428oc","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T10:58:05Z","timestamp":1652785085000},"page":"758-766","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":53,"title":["Twenty-Year Experience and Outcomes in a National Pediatric Pulmonary Hypertension Service"],"prefix":"10.1093","volume":"206","author":[{"given":"Andrew","family":"Constantine","sequence":"first","affiliation":[{"name":"National Pediatric Pulmonary Hypertension Service UK, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom"},{"name":"Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, United Kingdom"},{"name":"National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton and Harefield Hospitals, Guy\u2019s and St. Thomas\u2019 National Health Service Foundation Trust, London, United Kingdom"},{"name":"National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila G.","family":"Haworth","sequence":"additional","affiliation":[{"name":"National Pediatric Pulmonary Hypertension Service UK, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom"},{"name":"University College London Institute of Cardiovascular Science, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Muthurangu","sequence":"additional","affiliation":[{"name":"University College London Institute of Cardiovascular Science, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-2340","authenticated-orcid":false,"given":"Shahin","family":"Moledina","sequence":"additional","affiliation":[{"name":"National Pediatric Pulmonary Hypertension Service UK, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom"},{"name":"University College London Institute of Cardiovascular Science, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"2026022021195079400_bib1","doi-asserted-by":"crossref","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Respir J"},{"key":"2026022021195079400_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201406-1052OC","article-title":"Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry","volume":"190","author":"del Cerro Mar\u00edn","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021195079400_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"2026022021195079400_bib4","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"2026022021195079400_bib5","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/eurheartj\/ehab724.1972","article-title":"Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service","volume":"42","author":"Constantine","year":"2021","journal-title":"Eur Heart J"},{"key":"2026022021195079400_bib6","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"2026022021195079400_bib7","first-page":"1","article-title":"Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts","volume":"63","author":"Flegal","year":"2013","journal-title":"Natl Health Stat Rep"},{"key":"2026022021195079400_bib8","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1542\/peds.2015-1652","article-title":"Growth charts for children with Down Syndrome in the United States","volume":"136","author":"Zemel","year":"2015","journal-title":"Pediatrics"},{"key":"2026022021195079400_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"},{"key":"2026022021195079400_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2026022021195079400_bib11","author":"Estimates of the population for the UK"},{"key":"2026022021195079400_bib12","doi-asserted-by":"crossref","first-page":"E1717","DOI":"10.3390\/jcm9061717","article-title":"Children and adolescents with pulmonary arterial hypertension: baseline and follow-up data from the Polish Registry of Pulmonary Hypertension (BNP-PL)","volume":"9","author":"Kwiatkowska","year":"2020","journal-title":"J Clin Med"},{"key":"2026022021195079400_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/hrt.2009.182378","article-title":"Childhood idiopathic pulmonary arterial hypertension: a national cohort study","volume":"96","author":"Moledina","year":"2010","journal-title":"Heart"},{"key":"2026022021195079400_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/690007","article-title":"Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population","volume":"7","author":"Li","year":"2017","journal-title":"Pulm Circ"},{"key":"2026022021195079400_bib15","doi-asserted-by":"crossref","first-page":"2045894020977300","DOI":"10.1177\/2045894020977300","article-title":"Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review","volume":"11","author":"Leber","year":"2021","journal-title":"Pulm Circ"},{"key":"2026022021195079400_bib16","doi-asserted-by":"crossref","first-page":"2003337","DOI":"10.1183\/13993003.03337-2020","article-title":"Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry","volume":"59","author":"Abman","year":"2021","journal-title":"Eur Respir J"},{"key":"2026022021195079400_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"2026022021195079400_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.201406-1052OC","article-title":"Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry","volume":"190","author":"Mar\u00edn","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021195079400_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"2026022021195079400_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.113.005698","article-title":"STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension","volume":"129","author":"Barst","year":"2014","journal-title":"Circulation"},{"key":"2026022021195079400_bib21","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachi\u00e9ry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026022021195079400_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.athoracsur.2017.03.022","article-title":"Primary pulmonary vein stenosis: outcomes, risk factors, and severity score in a multicentric study","volume":"104","author":"Kalfa","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2026022021195079400_bib23","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2014.02.575","article-title":"Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies","volume":"63","author":"Zijlstra","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026022021195079400_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/hrt.2010.195248","article-title":"Children deserve the same rights we do: the need for paediatric pulmonary arterial hypertension clinical drug development","volume":"96","author":"Barst","year":"2010","journal-title":"Heart"},{"key":"2026022021195079400_bib25","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1164\/rccm.201701-0150WS","article-title":"Enhancing insights into pulmonary vascular disease through a precision medicine approach. A joint NHLBI-Cardiovascular Medical Research and Education Fund workshop report","volume":"195","author":"Newman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021195079400_bib26","doi-asserted-by":"crossref","first-page":"e011306","DOI":"10.1161\/JAHA.118.011306","article-title":"New strategies for the conduct of clinical trials in pediatric pulmonary arterial hypertension: outcome of a multistakeholder meeting with patients, academia, industry, and regulators, held at the European Medicines Agency on Monday, June 12, 2017","volume":"8","author":"Ollivier","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/206\/6\/758\/67001433\/ajrccm_206_6_758.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/206\/6\/758\/67001433\/ajrccm_206_6_758.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:20:01Z","timestamp":1771640401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/206\/6\/758\/8491841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,9,15]]},"published-print":{"date-parts":[[2022,9,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202110-2428oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9]]},"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"2021-10-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}